Innospec (IOSP) Cost of Revenue (2010 - 2026)

Innospec (IOSP) has 17 years of Cost of Revenue data on file, last reported at $329.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 4.43% year-over-year to $329.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 2.03% YoY), and the FY2025 full-year result was $1.3 billion, down 1.3% from the prior year.
• Cost of Revenue was little changed at $329.7 million in Q1 2026, from $328.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $361.8 million in Q1 2023 to a low of $308.1 million in Q2 2024.
• A 5-year average of $332.5 million and a median of $329.7 million in 2026 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue jumped 39.49% in 2022 and retreated 8.43% in 2023, its largest moves.
• Tracing IOSP's Cost of Revenue over 5 years: stood at $359.1 million in 2022, then decreased by 5.6% to $339.0 million in 2023, then retreated by 2.48% to $330.6 million in 2024, then slipped by 0.73% to $328.2 million in 2025, then grew by 0.46% to $329.7 million in 2026.
• Business Quant data shows IOSP's Cost of Revenue at $329.7 million in Q1 2026, $328.2 million in Q4 2025, and $325.2 million in Q3 2025.